期刊文献+

新诊断2型糖尿病患者血浆内脂素及FFA水平的变化 被引量:2

Change of plasma visfatin and free fatty acids levels in patients with newly diagnosed type 2 diabetes mellitus
下载PDF
导出
摘要 目的:探讨新诊断2型糖尿病患者血浆内脂素及游离脂肪酸水平的变化。方法:检测106例T2DM患者(T2DM组)和100例健康体检者(对照组)血浆内脂素、FFA和相关临床指标。结果:T2DM患者血浆内脂素、FFA水平高于正常对照组(P<0.01)。多元线性逐步回归分析显示腰臀比和空腹血糖是影响血浆内脂素水平的独立相关因素。结论:血浆内脂素水平变化与糖脂代谢关系密切,它可能在T2DM的发病机制中起着一定作用。 Objective To investigate the change of plasma visfatin and free fatty acids (FFA) levels in patients with newly diagnosed type 2 diabetes mellitus (T2DM). Methods Plasma visfatin and FFA concentrations and clinical indicators were measured in 106 patients with newly diagnosed T2DM (T2DM group) and 100 normal control subjects (control group). Results Plasma visfatin and FFA levels in T2DM group were higher than those in control group (P 〈 0.01 ). Multi-dimensional linear stepwise regression analysis showed waist to hip ratio(WHR) and fasting blood glucose (FBG) were independent associated factors which affected plasma visfatin level. Conclusions The change of plasma visfatin level is associated closely with metabolism of glucose and lipid, that may plays a role in the pathogenesis of T2DM.
出处 《实用医学杂志》 CAS 北大核心 2011年第20期3689-3691,共3页 The Journal of Practical Medicine
关键词 糖尿病 2型 内脂素 游离脂肪酸 Diabetes mellitus, type 2 Visfatin FFA
  • 相关文献

参考文献9

  • 1Takebayashi K,Suetsugu M,Wakabayashi S,et al.Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus[J].Metabolism,2007,56(4):451-458.
  • 2Boden G.Free fatty acids as target for therapy[J].Curr Opin Endocrinol Diab,2004,11 (5):258-263.
  • 3Garg A.Adipose tissue dysfunction in obesity and lipodystrophy[J].Clin Cornerstone,2006,8(Suppl)4:S7-S13.
  • 4Retnakaran R,Youn B S,Liu Y,et al.Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes:a cross-sectional study[J].Clin Endocrinol(Oxf),2008,69(6):885-893.
  • 5Chen M P,Chung F M,Chang D M,et al.Elevated Plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus[J].J Clin Endoerinol Metab,2006,91(1):295-299.
  • 6唱丽荣,毕锡娟,周桂霞.2型糖尿病及合并冠心病患者内脏脂肪素表达差异及临床意义[J].实用医学杂志,2010,26(7):1179-1180. 被引量:19
  • 7杨媚,杨刚毅,李伶,李清明,阮华玲,阳皓,李钶,孙勤,唐毅,Gunther Boden.不同糖耐量个体血浆内脂素水平的变化[J].中华内分泌代谢杂志,2006,22(3):245-247. 被引量:76
  • 8Fukuhara A,Matsuda M,Nishzawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin[J].Science,2005,307 (5708):426-430.
  • 9孙宏,袁重胜,刘艳,刘美娜,王滨有.社区成年人腹型肥胖与2型糖尿病的现况调查[J].中国公共卫生,2005,21(4):478-479. 被引量:21

二级参考文献15

  • 1李秀钧,董砚虎,程丽霞,柳林.糖尿病研究进展── 第16届国际糖尿病联盟大会纪要[J].中华内分泌代谢杂志,1998,14(2):72-77. 被引量:160
  • 2杨媚,杨刚毅,李伶,李清明,阮华玲,阳皓,李钶,孙勤,唐毅,Gunther Boden.不同糖耐量个体血浆内脂素水平的变化[J].中华内分泌代谢杂志,2006,22(3):245-247. 被引量:76
  • 3Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein se-creted by visceral fat that mimics the effects of insulin [J]. Science, 2005,307 (5708) : 426-430.
  • 4Chen M P, Chung F M, Chang D M, et al. Elevated plasma level of vis-fatin/p re-B cell colony-enhancing factor in patients with type 2 diabetes mellitus [J ]. J Clin Endocrinol Metab, 2006,91 ( 1 ) : 295- 299.
  • 5Weyer C, Foley J E, Bogardus C, et al. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type 2 diabetes independent of insulin resistance [J]. Diabetologia,2000,43 (12) : 1498-1506.
  • 6Trayhum P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc,2001,60:329-339.
  • 7Hug C, Lodish HF. Visfatin: A new adipokine. Science, 2005,307:366-367.
  • 8Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science, 2005,307:426-430.
  • 9Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab, 2006,91:295-299.
  • 10Kralisch S, Klein J, Lossner U, et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol, 2005,185:R1-8.

共引文献109

同被引文献18

  • 1刘雅明,吴绥生,尹艳春,等.高脂血症与胆囊结石的关系[J].2006.32(4):708-710.
  • 2Sudha BB. Hepatic insulin resistance directly promotes formation of cholesterol gallstones[ J]. Nature medicine, 2008,14 ( 7 ) : 778 - 782.
  • 3Folkert K,Albert K. Chipping away at gallstones[ J ]. Nature medi- eine,2008,14(7) :715 -716.
  • 4Yoo sC, Eun JS. Insulin Resistance is associated with gallstone e- ven in non- obese, non- diabetic Korean Men[J]. J Korean Med Sei ,2008,23:644 - 650.
  • 5Chung Jr, Michael FL, Walter CW, et al. Macronutrients and In- sulin Resistance in Cholesterol Gallstone Disease[J]. American Journal of Gastroenterology,2008,103:2932 - 2939.
  • 6Barzilay J I, Abraham L, Heckbert S R, et al. The relation ofmarkersof inflammation to the developm- entofglucose disorders in th elderly:the cantiovascular health study [J]. Diabetes, 2001,50 : 2384-2389.
  • 7Lee H J, Her S H, lm Y S. et al. Significance of inflammatorymarkers in diabetic patientswith stable coronary artery disease [J]. Intern Med,2009, 24(3) : 212-219.
  • 8Fuktthara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin [Jl. Science, 2005,307 (5708) : 426-430.
  • 9Dahl T B, Yndestad A, Skjelland M, et al. Increased expres2sion of visfatin in lnacrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaqte destabilization [J]. Circulation,2007,115(8):972-980.
  • 10梁晓强,方邦江,张静喆.胰岛素抵抗和胆石病相关性的研究综述[J].中西医结合学报,2007,5(2):208-212. 被引量:4

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部